Metabolic Response to XD14 Treatment in Human Breast Cancer Cell Line MCF-7
XD14 is a 4-acyl pyrrole derivative, which was discovered by a high-throughput virtual screening experiment. XD14 inhibits bromodomain and extra-terminal domain (BET) proteins (BRD2, BRD3, BRD4 and BRDT) and consequently suppresses cell proliferation. In this study, metabolic profiling reveals the m...
Main Authors: | Daqiang Pan, Michel Kather, Lucas Willmann, Manuel Schlimpert, Christoph Bauer, Simon Lagies, Karin Schmidtkunz, Steffen U. Eisenhardt, Manfred Jung, Stefan Günther, Bernd Kammerer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/10/1772 |
Similar Items
-
Investigation the Effect of the Exposure Time of Docetaxel on MCF-7 Cell Line: An In-Vitro Assessment
by: Ali Ebrahimifard, et al.
Published: (2015-10-01) -
Magnetic nanoparticles sensitize MCF-7 breast cancer cells to doxorubicin-induced apoptosis
by: Aljarrah Khaled, et al.
Published: (2012-04-01) -
The Effect of Chrysin Nanoparticles in Preventing the Growth of Mcf-7 Cancer Cells
by: M Norouzi, et al.
Published: (2018-10-01) -
A Bottom-Up Synthesis Approach to Silver Nanoparticles Induces Anti-Proliferative and Apoptotic Activities Against MCF-7, MCF-7/TAMR-1 and MCF-10A Human Breast Cell Lines
by: Nurul Izzati Zulkifli, et al.
Published: (2020-09-01) -
Study of anti-cancer effects of Curcumin; formulation of Curcumin-loaded nano carrier and its toxicity effect on MCF-7 Cell line.
by: masoud zare shehneh, et al.
Published: (2019-05-01)